Cormorant Asset Management »

Cogent Biosciences shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.0M 225k 35.52
2023-09-30 $9.8M 1.0M 9.75
2023-06-30 $12M 1.0M 11.84
2023-03-31 $7.6M 700k 10.79
2022-12-31 $10M 900k 11.56
2022-09-30 $22M 1.5M 14.92
2022-06-30 $6.8M 750k 9.02

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Abivax Sa Sponsored Ads (ABVX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Eyepoint Com New (EYPT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Series Trust State Street Spd Put Option (XBI)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Bright Minds Biosciences Com New (DRUG)
Edgewise Therapeutics (EWTX)
Olema Pharmaceuticals (OLMA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Insmed Com Par $.01 (INSM)
Engene Holdings (ENGN)

View all positions for Cormorant Asset Management

Top funds holding Cogent Biosciences

FMR
BlackRock
Vanguard Group
Deerfield Management Company
Fairmount Funds Management
Rtw Investments
Kynam Capital Management
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors
Duquesne Family Office

View all funds holding Cogent Biosciences